Novimmune SA
Novimmune SA, headquartered in Switzerland (CH), is a pioneering biotechnology company specialising in the development of innovative therapeutic antibodies. Founded in 2007, Novimmune has made significant strides in the biopharmaceutical industry, focusing on areas such as oncology and autoimmune diseases. The company is renowned for its proprietary antibody discovery platform, which enables the creation of unique, high-affinity antibodies tailored to target specific disease mechanisms. Novimmune's commitment to advancing healthcare is reflected in its robust pipeline of clinical candidates, positioning it as a key player in the global biotechnology landscape. With a strong emphasis on research and development, Novimmune continues to achieve notable milestones, contributing to the evolution of targeted therapies and improving patient outcomes worldwide.
DitchCarbon Score
How does Novimmune SA's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Research Services industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Novimmune SA's score of 26 is higher than 76% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Novimmune SA's reported carbon emissions
Novimmune SA, headquartered in Switzerland (CH), currently does not have publicly available carbon emissions data for the most recent year, nor specific reduction targets or initiatives outlined in their climate commitments. Without concrete figures or defined goals, it is challenging to assess their current carbon footprint or climate strategy. However, the absence of data does not preclude the company from engaging in sustainability efforts typical within the biopharmaceutical industry. Companies in this sector often focus on reducing their environmental impact through various initiatives, including energy efficiency improvements and sustainable sourcing practices. As the industry increasingly prioritises climate action, it is anticipated that Novimmune SA may develop and disclose more comprehensive climate commitments in the future.
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Novimmune SA is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
